{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:21:49Z","timestamp":1794025309374,"version":"4.8.0"},"reference-count":93,"publisher":"American Society of Hematology","issue":"26","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6,28]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Since a report of some 50 years ago describing refractory anemia associated with group C monosomy, monosomy 7 (\u22127) and interstitial deletions of chromosome 7 (del(7q)) have been established as one of the most frequent chromosomal aberrations found in essentially all types of myeloid tumors regardless of patient age and disease etiology. In the last century, researchers sought recessive myeloid tumor-suppressor genes by attempting to determine commonly deleted regions (CDRs) in del(7q) patients. However, these efforts were not successful. Today, tumor suppressors located in 7q are believed to act in a haploinsufficient fashion, and powerful new technologies such as microarray comparative genomic hybridization and high-throughput sequencing allow comprehensive searches throughout the genes encoded on 7q. Among those proposed as promising candidates, 4 have been validated by gene targeting in mouse models. SAMD9 (sterile \u03b1 motif domain 9) and SAMD9L (SAMD9-like) encode related endosomal proteins, mutations of which cause hereditary diseases with strong propensity to infantile myelodysplastic syndrome (MDS) harboring monosomy 7. Because MDS develops in SAMD9L-deficient mice over their lifetime, SAMD9\/SAMD9L are likely responsible for sporadic MDS with \u22127\/del(7q) as the sole anomaly. EZH2 (enhancer of zeste homolog 2) and MLL3 (mixed lineage leukemia 3) encode histone-modifying enzymes; loss-of-function mutations of these are detected in some myeloid tumors at high frequencies. In contrast to SAMD9\/SAMD9L, loss of EZH2 or MLL3 likely contributes to myeloid tumorigenesis in cooperation with additional specific gene alterations such as of TET2 or genes involved in the p53\/Ras pathway, respectively. Distinctive roles with different significance of the loss of multiple responsible genes render the complex nature of myeloid tumors carrying \u22127\/del(7q).<\/jats:p>","DOI":"10.1182\/blood-2017-12-822262","type":"journal-article","created":{"date-parts":[[2018,4,3]],"date-time":"2018-04-03T14:55:31Z","timestamp":1522767331000},"page":"2891-2898","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":87,"title":["The enigma of monosomy 7"],"prefix":"10.1182","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3455-6010","authenticated-orcid":false,"given":"Toshiya","family":"Inaba","sequence":"first","affiliation":[{"name":"Department of Molecular Oncology and Leukemia Program Project, Research Institute for Radiation Biology and Medicine, Hiroshima University, Hiroshima, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Honda","sequence":"additional","affiliation":[{"name":"Field of Human Disease Models, Major in Advanced Life Sciences and Medicine, Tokyo Women\u2019s Medical University, Tokyo, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Matsui","sequence":"additional","affiliation":[{"name":"Department of Molecular Laboratory Medicine, Faculty of Life Sciences, Kumamoto University, Kumamoto, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2019111910422993600_B1","first-page":"284","article-title":"Refractory anemia, granulocytic hyperplasia of bone marrow, and a missing chromosome in marrow cells. A new clinical syndrome?","volume":"12","author":"Freireich","year":"1964","journal-title":"Clin Res"},{"issue":"19","key":"2019111910422993600_B2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1056\/NEJM198111053051917","article-title":"Monosomy 7 syndrome","volume":"305","author":"Gyger","year":"1981","journal-title":"N Engl J Med"},{"issue":"6","key":"2019111910422993600_B3","doi-asserted-by":"crossref","first-page":"e236","DOI":"10.1097\/MPH.0b013e3181e75759","article-title":"Familial childhood monosomy 7 and associated myelodysplasia","volume":"32","author":"Gaitonde","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"issue":"11","key":"2019111910422993600_B4","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2015-09-669937","article-title":"Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents","volume":"127","author":"Wlodarski","year":"2016","journal-title":"Blood"},{"issue":"7","key":"2019111910422993600_B5","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1002\/(SICI)1097-0142(19970401)79:7<1438::AID-CNCR22>3.0.CO;2-#","article-title":"Monosomy 7 myelodysplastic syndrome and other second malignant neoplasms in children with neurofibromatosis type 1","volume":"79","author":"Maris","year":"1997","journal-title":"Cancer"},{"key":"2019111910422993600_B6","doi-asserted-by":"crossref","first-page":"17032","DOI":"10.1038\/nrdp.2017.32","article-title":"Severe congenital neutropenias","volume":"3","author":"Skokowa","year":"2017","journal-title":"Nat Rev Dis Primers"},{"issue":"9","key":"2019111910422993600_B7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrc.2017.60","article-title":"Therapy-related myeloid neoplasms: when genetics and environment collide","volume":"17","author":"McNerney","year":"2017","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"2019111910422993600_B8","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"issue":"10","key":"2019111910422993600_B9","first-page":"3534","article-title":"Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases","volume":"89","author":"Niemeyer","year":"1997","journal-title":"Blood"},{"issue":"3","key":"2019111910422993600_B10","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/sj.leu.2401342","article-title":"Myelodysplastic syndrome, juvenile myelomonocytic leukemia, and acute myeloid leukemia associated with complete or partial monosomy 7","volume":"13","author":"Hasle","year":"1999","journal-title":"Leukemia"},{"issue":"19","key":"2019111910422993600_B11","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.1182\/blood-2010-04-280313","article-title":"Complex karyotype newly defined: the strongest prognostic factor in advanced childhood myelodysplastic syndrome","volume":"116","author":"G\u00f6hring","year":"2010","journal-title":"Blood"},{"issue":"6","key":"2019111910422993600_B12","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1182\/blood-2002-11-3444","article-title":"Refractory anemia in childhood: a retrospective analysis of 67 patients with particular reference to monosomy 7","volume":"102","author":"Kardos","year":"2003","journal-title":"Blood"},{"issue":"12","key":"2019111910422993600_B13","doi-asserted-by":"crossref","first-page":"2655","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2655::AID-CNCR23>3.0.CO;2-W","article-title":"Transient monosomy 7: a case series in children and review of the literature","volume":"85","author":"Mantadakis","year":"1999","journal-title":"Cancer"},{"issue":"3","key":"2019111910422993600_B14","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1172\/JCI114262","article-title":"Familial bone marrow monosomy 7. Evidence that the predisposing locus is not on the long arm of chromosome 7","volume":"84","author":"Shannon","year":"1989","journal-title":"J Clin Invest"},{"issue":"1","key":"2019111910422993600_B15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0888-7543(05)80293-9","article-title":"Evidence implicating heterozygous deletion of chromosome 7 in the pathogenesis of familial leukemia associated with monosomy 7","volume":"14","author":"Shannon","year":"1992","journal-title":"Genomics"},{"issue":"2","key":"2019111910422993600_B16","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0165-4608(00)00344-7","article-title":"Familial partial monosomy 7 and myelodysplasia: different parental origin of the monosomy 7 suggests action of a mutator gene","volume":"124","author":"Minelli","year":"2001","journal-title":"Cancer Genet Cytogenet"},{"issue":"3","key":"2019111910422993600_B17","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood.V100.3.786","article-title":"Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children","volume":"100","author":"Kojima","year":"2002","journal-title":"Blood"},{"issue":"4","key":"2019111910422993600_B18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/sj.leu.2403663","article-title":"An acquired G-CSF receptor mutation results in increased proliferation of CMML cells from a patient with severe congenital neutropenia","volume":"19","author":"Germeshausen","year":"2005","journal-title":"Leukemia"},{"issue":"3","key":"2019111910422993600_B19","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0950-3536(97)80027-3","article-title":"Granulocyte colony-stimulating factor receptor mutations in severe chronic neutropenia and acute myeloid leukaemia: biological and clinical significance","volume":"10","author":"Touw","year":"1997","journal-title":"Baillieres Clin Haematol"},{"issue":"39","key":"2019111910422993600_B20","doi-asserted-by":"crossref","first-page":"14483","DOI":"10.1073\/pnas.0605245103","article-title":"Granulocyte colony-stimulating factor preferentially stimulates proliferation of monosomy 7 cells bearing the isoform IV receptor","volume":"103","author":"Sloand","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"2019111910422993600_B21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1182\/blood.V100.3.741","article-title":"G-CSF and monosomy 7 in marrow failure patients","volume":"100","author":"Young","year":"2002","journal-title":"Blood"},{"issue":"9","key":"2019111910422993600_B22","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1001\/jama.289.9.1130","article-title":"Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome","volume":"289","author":"Rosenfeld","year":"2003","journal-title":"JAMA"},{"issue":"9249","key":"2019111910422993600_B23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(00)03574-1","article-title":"Treatment of aplastic anaemia with granulocyte-colony stimulating factor and risk of malignancy","volume":"357","author":"Locasciulli","year":"2001","journal-title":"Lancet"},{"issue":"9","key":"2019111910422993600_B24","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1182\/blood-2011-04-348508","article-title":"Effects of granulocyte-colony stimulating factor on chromosome aneuploidy and replication asynchrony in healthy peripheral blood stem cell donors","volume":"118","author":"Hirsch","year":"2011","journal-title":"Blood"},{"issue":"3","key":"2019111910422993600_B25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/S0145-2126(03)00263-7","article-title":"Pancytopenia presenting with monosomy 7 which disappeared after immunosuppressive therapy","volume":"28","author":"Nagasawa","year":"2004","journal-title":"Leuk Res"},{"issue":"14","key":"2019111910422993600_B26","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1182\/blood-2013-11-538025","article-title":"Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis","volume":"123","author":"Skokowa","year":"2014","journal-title":"Blood"},{"issue":"7842","key":"2019111910422993600_B27","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(73)93347-3","article-title":"Letter: Deletions of chromosome 7 in haematological disorders","volume":"2","author":"Rowley","year":"1973","journal-title":"Lancet"},{"issue":"3","key":"2019111910422993600_B28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1182\/blood-2002-05-1459","article-title":"High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients","volume":"101","author":"Barjesteh van Waalwijk van Doorn-Khosrovani","year":"2003","journal-title":"Blood"},{"issue":"8","key":"2019111910422993600_B29","doi-asserted-by":"crossref","first-page":"4329","DOI":"10.1182\/blood-2007-10-119230","article-title":"High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated","volume":"111","author":"Lugthart","year":"2008","journal-title":"Blood"},{"issue":"12","key":"2019111910422993600_B30","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1200\/JCO.2009.26.0646","article-title":"High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities","volume":"28","author":"Gr\u00f6schel","year":"2010","journal-title":"J Clin Oncol"},{"issue":"11","key":"2019111910422993600_B31","doi-asserted-by":"crossref","first-page":"4641","DOI":"10.1182\/blood-2006-10-051342","article-title":"Monosomy 7 and deletion 7q in children and adolescents with acute myeloid leukemia: an international retrospective study","volume":"109","author":"Hasle","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2019111910422993600_B32","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/nm.2088","article-title":"Genomic instability and myelodysplasia with monosomy 7 consequent to EVI1 activation after gene therapy for chronic granulomatous disease","volume":"16","author":"Stein","year":"2010","journal-title":"Nat Med"},{"issue":"1","key":"2019111910422993600_B33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/cncr.26279","article-title":"Better prognosis for patients with del(7q) than for patients with monosomy 7 in myelodysplastic syndrome","volume":"118","author":"Cordoba","year":"2012","journal-title":"Cancer"},{"issue":"7","key":"2019111910422993600_B34","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/ajh.23230","article-title":"Sole abnormalities of chromosome 7 in myeloid malignancies: spectrum, histopathologic correlates, and prognostic implications","volume":"87","author":"Hussain","year":"2012","journal-title":"Am J Hematol"},{"key":"2019111910422993600_B35","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.leukres.2017.01.016","article-title":"Clinical significance of isolated del(7p) in myeloid neoplasms","volume":"55","author":"Gur","year":"2017","journal-title":"Leuk Res"},{"issue":"19","key":"2019111910422993600_B36","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1038\/onc.2014.196","article-title":"-7\/7q- syndrome in myeloid-lineage hematopoietic malignancies: attempts to understand this complex disease entity","volume":"34","author":"Honda","year":"2015","journal-title":"Oncogene"},{"issue":"1","key":"2019111910422993600_B37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1046\/j.1365-2141.2001.02713.x","article-title":"Molecular characterization of a myelodysplasia-associated chromosome 7 inversion","volume":"113","author":"Todd","year":"2001","journal-title":"Br J Haematol"},{"issue":"25","key":"2019111910422993600_B38","doi-asserted-by":"crossref","first-page":"6109","DOI":"10.1182\/blood-2011-12-397620","article-title":"Loss of heterozygosity in 7q myeloid disorders: clinical associations and genomic pathogenesis","volume":"119","author":"Jerez","year":"2012","journal-title":"Blood"},{"issue":"7","key":"2019111910422993600_B39","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/leu.2009.53","article-title":"Deletion 5q in myelodysplastic syndrome: a paradigm for the study of hemizygous deletions in cancer","volume":"23","author":"Ebert","year":"2009","journal-title":"Leukemia"},{"issue":"5","key":"2019111910422993600_B40","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1053\/j.seminoncol.2011.04.010","article-title":"Molecular dissection of the 5q deletion in myelodysplastic syndrome","volume":"38","author":"Ebert","year":"2011","journal-title":"Semin Oncol"},{"issue":"6","key":"2019111910422993600_B41","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1038\/leu.2014.25","article-title":"Recurrent genetic defects on chromosome 7q in myeloid neoplasms","volume":"28","author":"Hosono","year":"2014","journal-title":"Leukemia"},{"issue":"5","key":"2019111910422993600_B42","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1038\/bcj.2013.16","article-title":"Putative RNA-splicing gene LUC7L2 on 7q34 represents a candidate gene in pathogenesis of myeloid malignancies","volume":"3","author":"Singh","year":"2013","journal-title":"Blood Cancer J"},{"issue":"7","key":"2019111910422993600_B43","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1038\/sj.leu.2403810","article-title":"Genomic gains and losses influence expression levels of genes located within the affected regions: a study on acute myeloid leukemias with trisomy 8, 11, or 13, monosomy 7, or deletion 5q","volume":"19","author":"Schoch","year":"2005","journal-title":"Leukemia"},{"issue":"25","key":"2019111910422993600_B44","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1182\/blood-2017-08-803353","article-title":"Single-cell RNA-seq reveals a distinct transcriptome signature of aneuploid hematopoietic cells","volume":"130","author":"Zhao","year":"2017","journal-title":"Blood"},{"issue":"6","key":"2019111910422993600_B45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/nbt.3178","article-title":"Functional analysis of a chromosomal deletion associated with myelodysplastic syndromes using isogenic human induced pluripotent stem cells","volume":"33","author":"Kotini","year":"2015","journal-title":"Nat Biotechnol"},{"issue":"22","key":"2019111910422993600_B46","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1182\/blood-2009-07-232504","article-title":"Use of chromosome engineering to model a segmental deletion of chromosome band 7q22 found in myeloid malignancies","volume":"115","author":"Wong","year":"2010","journal-title":"Blood"},{"key":"2019111910422993600_B47","doi-asserted-by":"crossref","first-page":"e07839","DOI":"10.7554\/eLife.07839","article-title":"Functional evidence implicating chromosome 7q22 haploinsufficiency in myelodysplastic syndrome pathogenesis","volume":"4","author":"Wong","year":"2015","journal-title":"eLife"},{"issue":"2","key":"2019111910422993600_B48","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.bbrc.2009.04.004","article-title":"Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome","volume":"383","author":"Asou","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2019111910422993600_B49","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.molcel.2012.06.033","article-title":"Poly-ADP ribosylation of Miki by tankyrase-1 promotes centrosome maturation","volume":"47","author":"Ozaki","year":"2012","journal-title":"Mol Cell"},{"issue":"1","key":"2019111910422993600_B50","doi-asserted-by":"crossref","first-page":"e8676","DOI":"10.1371\/journal.pone.0008676","article-title":"Identification of two critically deleted regions within chromosome segment 7q35-q36 in EVI1 deregulated myeloid leukemia cell lines","volume":"5","author":"De Weer","year":"2010","journal-title":"PLoS One"},{"issue":"8","key":"2019111910422993600_B51","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/ng.620","article-title":"Somatic mutations of the histone methyltransferase gene EZH2 in myelodysplastic syndromes","volume":"42","author":"Nikoloski","year":"2010","journal-title":"Nat Genet"},{"issue":"5","key":"2019111910422993600_B52","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.ccr.2014.03.016","article-title":"MLL3 is a haploinsufficient 7q tumor suppressor in acute myeloid leukemia","volume":"25","author":"Chen","year":"2014","journal-title":"Cancer Cell"},{"issue":"3","key":"2019111910422993600_B53","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ccr.2013.08.011","article-title":"Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7","volume":"24","author":"Nagamachi","year":"2013","journal-title":"Cancer Cell"},{"issue":"D1","key":"2019111910422993600_B54","doi-asserted-by":"crossref","first-page":"D710","DOI":"10.1093\/nar\/gkv1157","article-title":"Ensembl 2016","volume":"44","author":"Yates","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"2019111910422993600_B55","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1086\/508069","article-title":"A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis","volume":"79","author":"Topaz","year":"2006","journal-title":"Am J Hum Genet"},{"issue":"7","key":"2019111910422993600_B56","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/ng.3569","article-title":"SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7","volume":"48","author":"Narumi","year":"2016","journal-title":"Nat Genet"},{"issue":"5","key":"2019111910422993600_B57","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1172\/JCI91913","article-title":"Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans","volume":"127","author":"Buonocore","year":"2017","journal-title":"J Clin Invest"},{"issue":"6","key":"2019111910422993600_B58","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/j.ajhg.2016.04.009","article-title":"Ataxia-pancytopenia syndrome is caused by missense mutations in SAMD9L","volume":"98","author":"Chen","year":"2016","journal-title":"Am J Hum Genet"},{"issue":"16","key":"2019111910422993600_B59","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1182\/blood-2016-10-743302","article-title":"Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms","volume":"129","author":"Tesi","year":"2017","journal-title":"Blood"},{"issue":"5","key":"2019111910422993600_B60","doi-asserted-by":"crossref","first-page":"e183","DOI":"10.1212\/NXG.0000000000000183","article-title":"Ataxia-pancytopenia syndrome withSAMD9Lmutations","volume":"3","author":"Gorcenco","year":"2017","journal-title":"Neurol Genet"},{"issue":"7","key":"2019111910422993600_B61","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1182\/blood-2017-09-806489","article-title":"A landscape of germ line mutations in a cohort of inherited bone marrow failure patients","volume":"131","author":"Bluteau","year":"2018","journal-title":"Blood"},{"issue":"3","key":"2019111910422993600_B62","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3324\/haematol.2017.180778","article-title":"Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7","volume":"103","author":"Pastor","year":"2018","journal-title":"Haematologica"},{"issue":"1","key":"2019111910422993600_B63","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1038\/s41467-017-01590-5","article-title":"The genomic landscape of pediatric myelodysplastic syndromes","volume":"8","author":"Schwartz","year":"2017","journal-title":"Nat Commun"},{"issue":"3","key":"2019111910422993600_B64","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/leu.2016.342","article-title":"Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants","volume":"31","author":"Pastor","year":"2017","journal-title":"Leukemia"},{"issue":"5595","key":"2019111910422993600_B65","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1126\/science.1076997","article-title":"Role of histone H3 lysine 27 methylation in Polycomb-group silencing","volume":"298","author":"Cao","year":"2002","journal-title":"Science"},{"issue":"2","key":"2019111910422993600_B66","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0092-8674(02)00975-3","article-title":"Drosophila enhancer of Zeste\/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites","volume":"111","author":"Czermin","year":"2002","journal-title":"Cell"},{"issue":"2","key":"2019111910422993600_B67","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0092-8674(02)00976-5","article-title":"Histone methyltransferase activity of a Drosophila Polycomb group repressor complex","volume":"111","author":"M\u00fcller","year":"2002","journal-title":"Cell"},{"issue":"10","key":"2019111910422993600_B68","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/nrm2763","article-title":"Mechanisms of polycomb gene silencing: knowns and unknowns","volume":"10","author":"Simon","year":"2009","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"7330","key":"2019111910422993600_B69","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature09784","article-title":"The Polycomb complex PRC2 and its mark in life","volume":"469","author":"Margueron","year":"2011","journal-title":"Nature"},{"issue":"26","key":"2019111910422993600_B70","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1056\/NEJMoa1013343","article-title":"Clinical effect of point mutations in myelodysplastic syndromes","volume":"364","author":"Bejar","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"2019111910422993600_B71","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ng.621","article-title":"Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders","volume":"42","author":"Ernst","year":"2010","journal-title":"Nat Genet"},{"issue":"12","key":"2019111910422993600_B72","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1056\/NEJMoa1112304","article-title":"Prognostic relevance of integrated genetic profiling in acute myeloid leukemia","volume":"366","author":"Patel","year":"2012","journal-title":"N Engl J Med"},{"issue":"1","key":"2019111910422993600_B73","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/leu.2013.288","article-title":"EZH2 in normal and malignant hematopoiesis","volume":"28","author":"Lund","year":"2014","journal-title":"Leukemia"},{"issue":"7","key":"2019111910422993600_B74","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1101\/gad.186411.111","article-title":"A key role for EZH2 and associated genes in mouse and human adult T-cell acute leukemia","volume":"26","author":"Simon","year":"2012","journal-title":"Genes Dev"},{"issue":"6","key":"2019111910422993600_B75","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/leu.2013.80","article-title":"Multiple mechanisms deregulate EZH2 and histone H3 lysine 27 epigenetic changes in myeloid malignancies","volume":"27","author":"Khan","year":"2013","journal-title":"Leukemia"},{"issue":"12","key":"2019111910422993600_B76","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1084\/jem.20131144","article-title":"Concurrent loss of Ezh2 and Tet2 cooperates in the pathogenesis of myelodysplastic disorders","volume":"210","author":"Muto","year":"2013","journal-title":"J Exp Med"},{"key":"2019111910422993600_B77","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.1038\/ncomms5177","article-title":"Ezh2 loss promotes development of myelodysplastic syndrome but attenuates its predisposition to leukaemic transformation","volume":"5","author":"Sashida","year":"2014","journal-title":"Nat Commun"},{"issue":"10","key":"2019111910422993600_B78","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1182\/blood-2015-03-634428","article-title":"Ezh2 loss in hematopoietic stem cells predisposes mice to develop heterogeneous malignancies in an Ezh1-dependent manner","volume":"126","author":"Mochizuki-Kashio","year":"2015","journal-title":"Blood"},{"issue":"8","key":"2019111910422993600_B79","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1111\/j.1742-4658.2010.07606.x","article-title":"Mixed lineage leukemia: roles in gene expression, hormone signaling and mRNA processing","volume":"277","author":"Ansari","year":"2010","journal-title":"FEBS J"},{"issue":"6","key":"2019111910422993600_B80","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.molcel.2014.02.033","article-title":"Enhancer malfunction in cancer","volume":"53","author":"Herz","year":"2014","journal-title":"Mol Cell"},{"issue":"10","key":"2019111910422993600_B81","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1182\/blood-2011-09-380444","article-title":"High-resolution genomic profiling of adult and pediatric core-binding factor acute myeloid leukemia reveals new recurrent genomic alterations","volume":"119","author":"K\u00fchn","year":"2012","journal-title":"Blood"},{"issue":"18","key":"2019111910422993600_B82","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1182\/blood-2011-12-401471","article-title":"Commonly altered genomic regions in acute myeloid leukemia are enriched for somatic mutations involved in chromatin remodeling and splicing","volume":"120","author":"Dolnik","year":"2012","journal-title":"Blood"},{"issue":"2","key":"2019111910422993600_B83","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.stem.2008.11.015","article-title":"Hierarchical maintenance of MLL myeloid leukemia stem cells employs a transcriptional program shared with embryonic rather than adult stem cells","volume":"4","author":"Somervaille","year":"2009","journal-title":"Cell Stem Cell"},{"issue":"4","key":"2019111910422993600_B84","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/leu.2010.31","article-title":"Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells","volume":"24","author":"Pellagatti","year":"2010","journal-title":"Leukemia"},{"issue":"1","key":"2019111910422993600_B85","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/ng0492-50","article-title":"Human CCAAT displacement protein is homologous to the Drosophila homeoprotein, cut","volume":"1","author":"Neufeld","year":"1992","journal-title":"Nat Genet"},{"issue":"6174","key":"2019111910422993600_B86","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/333629a0","article-title":"Primary structure and expression of a product from cut, a locus involved in specifying sensory organ identity in Drosophila","volume":"333","author":"Blochlinger","year":"1988","journal-title":"Nature"},{"issue":"10","key":"2019111910422993600_B87","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrc3805","article-title":"CUX1, a haploinsufficient tumour suppressor gene overexpressed in advanced cancers","volume":"14","author":"Ramdzan","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"2019111910422993600_B88","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/ng.2846","article-title":"Inactivating CUX1 mutations promote tumorigenesis","volume":"46","author":"Wong","year":"2014","journal-title":"Nat Genet"},{"issue":"5","key":"2019111910422993600_B89","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1128\/MCB.22.5.1424-1437.2002","article-title":"Genetic ablation of the CDP\/Cux protein C terminus results in hair cycle defects and reduced male fertility","volume":"22","author":"Luong","year":"2002","journal-title":"Mol Cell Biol"},{"issue":"13","key":"2019111910422993600_B90","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood.V98.13.3658","article-title":"Lymphoid apoptosis and myeloid hyperplasia in CCAAT displacement protein mutant mice","volume":"98","author":"Sinclair","year":"2001","journal-title":"Blood"},{"issue":"17","key":"2019111910422993600_B91","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1101\/gad.200101","article-title":"The transcriptional repressor CDP (Cutl1) is essential for epithelial cell differentiation of the lung and the hair follicle","volume":"15","author":"Ellis","year":"2001","journal-title":"Genes Dev"},{"issue":"5","key":"2019111910422993600_B92","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(03)00155-7","article-title":"DOCK4, a GTPase activator, is disrupted during tumorigenesis","volume":"112","author":"Yajnik","year":"2003","journal-title":"Cell"},{"issue":"46","key":"2019111910422993600_B93","doi-asserted-by":"crossref","first-page":"E6359","DOI":"10.1073\/pnas.1516394112","article-title":"Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes","volume":"112","author":"Sundaravel","year":"2015","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/26\/2891\/1465937\/blood822262.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/131\/26\/2891\/1465937\/blood822262.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T13:47:21Z","timestamp":1574171241000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/131\/26\/2891\/39117\/The-enigma-of-monosomy-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,28]]},"references-count":93,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2018,6,28]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2017-12-822262","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,28]]}}}